Is INFU research on Rallies investment advice?

No. Rallies provides research, data, and educational context for INFU. It does not provide personalized investment advice.

INFU (InfuSystem Holdings, Inc.) Stock Analysis - Financials

InfuSystem Holdings, Inc. (INFU) is a publicly traded Healthcare sector company. As of November 3, 2026, INFU trades at $13.51 with a market cap of $280.23M and a P/E ratio of 31.79. INFU moved -2.41% today. Year to date, INFU is +64.48%; over the trailing twelve months it is +33.20%. Its 52-week range spans $4.61 to $14.64. Analyst consensus is strong buy with an average price target of $18.75. Rallies surfaces INFU's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are INFU's key financials?

INFU financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. INFU recently traded at $13.51. Market cap is $280.23M. P/E ratio is 31.79. Revenue is $143.34M.

INFU Key Metrics

Key financial metrics for INFU
Metric	Value
Price	$13.51
Market Cap	$280.23M
P/E Ratio	31.79
EPS	$0.42
Dividend Yield	0.00%
52-Week High	$14.64
52-Week Low	$4.61
Volume	1.89K
Avg Volume	0
Revenue (TTM)	$143.34M
Net Income	$8.54M
Gross Margin	57.45%

INFU Analyst Consensus

3 analysts cover INFU: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $18.75.

Common questions about INFU

What are INFU's key financials?: INFU financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. INFU recently traded at $13.51. Market cap is $280.23M. P/E ratio is 31.79. Revenue is $143.34M.
Is INFU research on Rallies investment advice?: No. Rallies provides research, data, and educational context for INFU. It does not provide personalized investment advice.